Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1270667 | 0.97 | ESR1 (0.39) | ESR1ESR2ALDH1A1TRPA1MAPK1 | |
| SCHEMBL852172 | 0.77 | MAPT (0.44) | ESR1ESR2ALDH1A1TRPA1MAPK1 | |
| SCHEMBL10950698 | 0.76 | PTGS1 (0.38) | — | |
| SCHEMBL1270651 | 0.76 | ESR1 (0.42) | ESR1ESR2ALDH1A1MAPTLMNA | |
| SCHEMBL9225762 | 0.76 | ESR1 (0.42) | ESR1ESR2ALDH1A1MAPTLMNA | |
| SCHEMBL10940146 | 0.75 | LMNA (0.40) | ALDH1A1GSK3BLMNAKMT2A | |
| SCHEMBL10444591 | 0.75 | ESR1 (0.38) | ESR1ESR2ALDH1A1TRPA1MAPK1 | |
| SCHEMBL3238058 | 0.75 | ESR1 (0.34) | ESR1ESR2MAPT | |
| SCHEMBL12191013 | 0.74 | ESR1 (0.41) | ESR1ESR2ALDH1A1MAPTLMNA | |
| SCHEMBL9358733 | 0.73 | ACHE (0.36) | LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031506-A | Chiral control | 波涛生命科学有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12583883-B2 | Asymmetric auxiliary group | WAVE LIFE SCIENCES LTD. (SG) | 2026-03-24 | — | — | US | disclosed |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD (SG) | 2026-02-26 | — | — | US | disclosed |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2025-09-30 | — | — | US | disclosed |
| US-20240229026-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES LTD. (SG) | 2024-07-11 | — | — | US | disclosed |
| US-20240174710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD. (SG) | 2024-05-30 | — | — | US | disclosed |
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
| EP-4219516-A2 | CHIRAL CONTROL | Wave Life Sciences Ltd. (SG) | 2023-08-02 | — | — | EP | disclosed |
| US-11643657-B2 | Chiral control | WAVE LIFE SCIENCES LTD. (SG) | 2023-05-09 | — | — | US | disclosed |
| EP-2872147-B1 | METHOD FOR MAKING CHIRAL OLIGONUCLEOTIDES | WAVE LIFE SCIENCES LTD (SG) | 2022-12-21 | — | — | EP | disclosed |
| US-9885037-B2 | — | — | 2018-02-06 | — | — | US | disclosed |
| US-20170275621-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES USA, INC. | 2017-09-28 | — | — | US | disclosed |
| US-9598458-B2 | Asymmetric auxiliary group | WAVE LIFE SCIENCES JAPAN, INC. (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20170029445-A1 | ASYMMETRIC AUXILIARY GROUP | WAVE LIFE SCIENCES JAPAN, INC. (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20150211006-A1 | CHIRAL CONTROL | WAVE LIFE SCIENCES USA, INC. | 2015-07-30 | — | — | US | disclosed |
| US-20150197540-A1 | ASYMMETRIC AUXILIARY GROUP | WAVE LIFE SCIENCES LTD. (SG) | 2015-07-16 | — | — | US | disclosed |
| EP-2872485-A1 | ASYMMETRIC AUXILIARY GROUP | WaVe Life Sciences Japan (JP) | 2015-05-20 | — | — | EP | disclosed |
| EP-2872147-A2 | CHIRAL CONTROL | Wave Life Sciences Pte. Ltd. (SG) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014012081-A2 | CHIRAL CONTROL | ONTORII, INC. (US) | 2014-01-16 | — | — | WO | disclosed |
| WO-2014010250-A1 | ASYMMETRIC AUXILIARY GROUP | CHIRALGEN, LTD. (JP) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | ESR1 2498/4885ESR2 4447/4885ALDH1A1 2134/4885 |
| US-20150197540-A1 | ASYMMETRIC AUXILIARY GROUP | NIT2, IDH1, HBG2 | ESR1 2744/4885ESR2 2273/4885ALDH1A1 1164/4885 |
| US-20170275621-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ESR1 1622/4885ESR2 3275/4885ALDH1A1 2867/4885 |
| US-20240229026-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ESR1 1622/4885ESR2 3275/4885ALDH1A1 2867/4885 |
| US-12583883-B2 | Asymmetric auxiliary group | AGL, RNMT, NSUN2 | ESR1 4522/4885ESR2 4164/4885ALDH1A1 1865/4885 |
| US-20170029445-A1 | ASYMMETRIC AUXILIARY GROUP | NIT2, IDH1, HBG2 | ESR1 2744/4885ESR2 2273/4885ALDH1A1 1164/4885 |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | ESR1 2498/4885ESR2 4447/4885ALDH1A1 2134/4885 |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | NSUN2, NSUN3, NOP2 | ESR1 2352/4885ESR2 2609/4885ALDH1A1 3107/4885 |
| US-20150211006-A1 | CHIRAL CONTROL | RNGTT, POLI, NSUN3 | ESR1 1622/4885ESR2 3275/4885ALDH1A1 2867/4885 |
| US-11643657-B2 | Chiral control | RNGTT, POLI, NSUN3 | ESR1 1622/4885ESR2 3275/4885ALDH1A1 2867/4885 |
| US-20240174710-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | ALKBH1, DUT, RNGTT | ESR1 2498/4885ESR2 4447/4885ALDH1A1 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.